Plandaí Biotechnology, Inc. (PLPL)
| Market Cap | 44.89K |
| Revenue (ttm) | 338.48K +215.3% |
| Net Income | -4.32M |
| EPS | -0.02 |
| Shares Out | 44.89B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 49 |
| Open | 0.0001 |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | 30.85 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Plandaí Biotechnology
Plandaí Biotechnology, Inc. does not have significant operations. Previously, it was involved in a biotechnology-related business. Plandaí Biotechnology, Inc. is based in Taipei, Taiwan. [Read more]
Financial Performance
In fiscal year 2016, Plandaí Biotechnology's revenue was $298,494, an increase of 221.31% compared to the previous year's $92,898. Losses were -$4.38 million, -54.30% less than in 2015.
Financial StatementsNews
Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet's (A Subsidiary Of Plandai – $PLPL) Business and Assets
ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. (the "Company,") (OTC PINK:PLPL), a leading innovator in revolutionary cleaning technology,...
Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O'Shea
ATHENS, GA / ACCESSWIRE / May 31, 2023 / ByoPlanet (OTC PINK:PLPL), a wholly owned subsidiary of Plandai Biotechnology, Inc. and a leading provider of innovative disinfection and building services sol...
ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams
ATHENS, GA / ACCESSWIRE / May 25, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biotechnology, Inc. (OTC PINK:PLPL), a leading provider of innovative cleaning and disinfection solutions, is p...
ByoPlanet and Merck Animal Health Announce Partnership with USEF
New collaboration to protect the health of animals through innovations in environmental infection control ATHENS, GA / ACCESSWIRE / May 23, 2023 / ByoPlanet, a wholly owned subsidiary of Plandai Biote...
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
ATHENS, GA / ACCESSWIRE / May 19, 2023 / ByoPlanet, a leading provider of advanced disinfection solutions and a wholly owned subsidiary of Plandai Biotechnology Inc. (the "Company") (OTC PINK:PLPL), i...
Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus
ATHENS, GA / ACCESSWIRE / May 18, 2023 / Plandai Biotechnology (OTC PINK:PLPL) is pleased to announce a comprehensive rebranding initiative following the successful completion of its share exchange ag...
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
ATHENS, GA / ACCESSWIRE / May 17, 2023 / Plandai Biotechnology, Inc. (OTC PINK:PLPL), a Nevada corporation ("PLPL" or "Plandai"), GOOD SALT, LLC, a Florida limited liability company doing business as ...
Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC
SAN DIEGO, CA / ACCESSWIRE / March 20, 2023 / Plandai Biotechnology, Inc. (OTC PINK:PLPL) announces it has entered into a binding memorandum of understanding to close a share exchange agreement with G...
Plandai Biotechnologies, Inc. Announces Entry into Non-Binding Letter of Intent, Updates on Status of Independent Audit
SAN DIEGO, CA / ACCESSWIRE / October 6, 2022 / (OTC PINK:PLPL) - Plandai Biotechnology, Inc. ("Plandai" or the "Company") announces its entry into a non-binding letter of intent with EV Hotel Corp., a...
SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action
SAN DIEGO, CA / ACCESSWIRE / June 22, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced that the U.S. Securities and Exchange Commission canceled civil penalties and in...
Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood's Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market
SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Plandai Biotechnology Inc. (OTC PINK:PLPL) (the "Company") today announced its entry into a non-binding letter of intent to enter into a new business throug...